- Thermo Fisher Scientific (NYSE:TMO) posted third-quarter profit and revenue that beat Wall Street estimates and raised its full year earnings forecast.
- Quarterly revenue increased nearly 10% to $9.33B, beating analysts' estimate by $920M.
- The company raised its 2021 revenue guidance by $1.2B to $37.1B vs analysts' consensus estimate of $36.09B.
- Also raised its adjusted profit per share forecast by $1.30 to $23.37, compared to consensus estimate of $22.21.
- Life Sciences Solutions Segment revenue grew 9% to $3.72B; Analytical Instruments Segment revenue grew 11% to $1.48B; Specialty Diagnostics Segment revenue was $1.36B in Q3 2021, compared with revenue of $1.43B last year; Laboratory Products and Services Segment revenue grew 12% to $3.49B.
- The company also posted adjusted quarterly profit of $5.76, beating analysts' estimate by $1.06.
- Previously (Oct. 27): Thermo Fisher Scientific EPS beats by $1.06, beats on revenue, boost FY21 guidance.
Thermo Fisher posts Q3 earnings beat, FY forecast raise
Recommended For You
About TMO Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
TMO | - | - |
Thermo Fisher Scientific Inc. |